🇺🇸 Adrenocorticotropic Hormone Gel in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 21 April 2025 – 21 April 2026
• Total reports: 22

Most-reported reactions

1. Atrial Fibrillation — 3 reports (13.64%)
2. Vomiting — 3 reports (13.64%)
3. Abdominal Pain — 2 reports (9.09%)
4. Anaemia — 2 reports (9.09%)
5. Bacterial Sepsis — 2 reports (9.09%)
6. Dehydration — 2 reports (9.09%)
7. Diarrhoea — 2 reports (9.09%)
8. Fluid Retention — 2 reports (9.09%)
9. Hypertension — 2 reports (9.09%)
10. Infection — 2 reports (9.09%)

Source database →

Frequently asked questions

Is Adrenocorticotropic Hormone Gel approved in United States?

Adrenocorticotropic Hormone Gel does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Adrenocorticotropic Hormone Gel in United States?

Rohit Aggarwal, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.